These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
606 related articles for article (PubMed ID: 35862802)
1. Angiotensin-Converting Enzyme 2 Potentiates SARS-CoV-2 Infection by Antagonizing Type I Interferon Induction and Its Down-Stream Signaling Pathway. Chen J; Liu J; Chen Z; Peng H; Zhu C; Feng D; Zhang S; Zhao P; Zhang X; Xu J mSphere; 2022 Aug; 7(4):e0021122. PubMed ID: 35862802 [TBL] [Abstract][Full Text] [Related]
2. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2. Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG mBio; 2020 Sep; 11(5):. PubMed ID: 32913009 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium. Zhou Y; Wang M; Li Y; Wang P; Zhao P; Yang Z; Wang S; Zhang L; Li Z; Jia K; Zhong C; Li N; Yu Y; Hou J Immunol Lett; 2021 Sep; 237():33-41. PubMed ID: 34228987 [TBL] [Abstract][Full Text] [Related]
4. Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform. Mpekoulis G; Frakolaki E; Taka S; Ioannidis A; Vassiliou AG; Kalliampakou KI; Patas K; Karakasiliotis I; Aidinis V; Chatzipanagiotou S; Angelakis E; Vassilacopoulou D; Vassilaki N PLoS One; 2021; 16(6):e0253458. PubMed ID: 34185793 [TBL] [Abstract][Full Text] [Related]
6. IFN-γ-mediated control of SARS-CoV-2 infection through nitric oxide. Silva BJA; Krogstad PA; Teles RMB; Andrade PR; Rajfer J; Ferrini MG; Yang OO; Bloom BR; Modlin RL Front Immunol; 2023; 14():1284148. PubMed ID: 38162653 [TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection. Li M; Ayyanathan K; Dittmar M; Miller J; Tapescu I; Lee JS; McGrath ME; Xue Y; Vashee S; Schultz DC; Frieman MB; Cherry S mBio; 2023 Aug; 14(4):e0119423. PubMed ID: 37377442 [TBL] [Abstract][Full Text] [Related]
8. Interaction of HDAC2 with SARS-CoV-2 NSP5 and IRF3 Is Not Required for NSP5-Mediated Inhibition of Type I Interferon Signaling Pathway. Naik NG; Lee SC; Veronese BHS; Ma Z; Toth Z Microbiol Spectr; 2022 Oct; 10(5):e0232222. PubMed ID: 36173315 [TBL] [Abstract][Full Text] [Related]
9. Differential roles of RIG-I like receptors in SARS-CoV-2 infection. Yang DM; Geng TT; Harrison AG; Wang PH Mil Med Res; 2021 Sep; 8(1):49. PubMed ID: 34488908 [TBL] [Abstract][Full Text] [Related]
10. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling. Zheng Y; Zhuang MW; Han L; Zhang J; Nan ML; Zhan P; Kang D; Liu X; Gao C; Wang PH Signal Transduct Target Ther; 2020 Dec; 5(1):299. PubMed ID: 33372174 [TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I/MDA5, TRIF, and STING signaling pathways. Deng J; Zheng Y; Zheng SN; Nan ML; Han L; Zhang J; Jin Y; Pan JA; Gao C; Wang PH J Med Virol; 2023 Mar; 95(3):e28561. PubMed ID: 36755358 [TBL] [Abstract][Full Text] [Related]
13. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis. Ramasamy S; Subbian S Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980688 [TBL] [Abstract][Full Text] [Related]
14. Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell. Puray-Chavez M; LaPak KM; Schrank TP; Elliott JL; Bhatt DP; Agajanian MJ; Jasuja R; Lawson DQ; Davis K; Rothlauf PW; Liu Z; Jo H; Lee N; Tenneti K; Eschbach JE; Shema Mugisha C; Cousins EM; Cloer EW; Vuong HR; VanBlargan LA; Bailey AL; Gilchuk P; Crowe JE; Diamond MS; Hayes DN; Whelan SPJ; Horani A; Brody SL; Goldfarb D; Major MB; Kutluay SB Cell Rep; 2021 Jul; 36(2):109364. PubMed ID: 34214467 [TBL] [Abstract][Full Text] [Related]
15. Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection Curreli F; Victor SMB; Ahmed S; Drelich A; Tong X; Tseng CK; Hillyer CD; Debnath AK mBio; 2020 Dec; 11(6):. PubMed ID: 33310780 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block. Burke JM; St Clair LA; Perera R; Parker R RNA; 2021 Nov; 27(11):1318-1329. PubMed ID: 34315815 [TBL] [Abstract][Full Text] [Related]
17. Mechanistic understanding of innate and adaptive immune responses in SARS-CoV-2 infection. Balkhi MY Mol Immunol; 2021 Jul; 135():268-275. PubMed ID: 33940513 [TBL] [Abstract][Full Text] [Related]
18. Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor. Onabajo OO; Banday AR; Stanifer ML; Yan W; Obajemu A; Santer DM; Florez-Vargas O; Piontkivska H; Vargas JM; Ring TJ; Kee C; Doldan P; Tyrrell DL; Mendoza JL; Boulant S; Prokunina-Olsson L Nat Genet; 2020 Dec; 52(12):1283-1293. PubMed ID: 33077916 [TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage. Sui Y; Li J; Venzon DJ; Berzofsky JA Front Immunol; 2021; 12():658428. PubMed ID: 34149696 [TBL] [Abstract][Full Text] [Related]